177 related articles for article (PubMed ID: 1195561)
1. Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.
Cort JH; Schück O; Stríbrná J; Skopková J; Jost K; Mulder JL
Kidney Int; 1975 Nov; 8(5):292-302. PubMed ID: 1195561
[TBL] [Abstract][Full Text] [Related]
2. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity.
Cort JH; Albrecht I; Nováková J; Mulder JL; Jost K
Eur J Clin Invest; 1975 Apr; 5(2):165-75. PubMed ID: 168085
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
[TBL] [Abstract][Full Text] [Related]
4. 2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.
Lammek B; Bankowski K; Misicka A; Manning M; Seto J; Sawyer WH
J Med Chem; 1989 Jan; 32(1):244-7. PubMed ID: 2909737
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
6. Effective antagonists of the antidiuretic action of vasopressin in rats.
Sawyer WH; Manning M
Ann N Y Acad Sci; 1982; 394():464-72. PubMed ID: 6960778
[No Abstract] [Full Text] [Related]
7. Antidiuretic antagonism and agonism of 1-deamino-pentamethylene-2-D-phenylalanine-4-isoleucine-arginine vasopressin in rats with diabetes insipidus.
Vilhardt H; Lundin S
J Endocrinol; 1987 Mar; 112(3):439-42. PubMed ID: 3559452
[TBL] [Abstract][Full Text] [Related]
8. Activation of rat kidney adenylate cyclase by vasopressin analogues: lack of correlation with antidiuretic activity.
Barth T; Rajerison MR; Roy C; Jard S
Mol Cell Endocrinol; 1975 Jan; 2(2):81-90. PubMed ID: 1149917
[TBL] [Abstract][Full Text] [Related]
9. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
10. Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
Gunnar E; Lindeberg G; Melin P; Larsson LE
Int J Pept Protein Res; 1976; 8(2):193-8. PubMed ID: 1270191
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
12. Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids.
Manning M; Przybylski J; Grzonka Z; Nawrocka E; Lammek B; Misicka A; Cheng LL; Chan WY; Wo NC; Sawyer WH
J Med Chem; 1992 Oct; 35(21):3895-904. PubMed ID: 1433200
[TBL] [Abstract][Full Text] [Related]
13. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
[TBL] [Abstract][Full Text] [Related]
15. Hydro-osmotic activity of "carba' analogues of oxytocin and [8-arginine] vasopressin on frog (Rana esculenta) bladder.
Barth T; Le Bars NC; Roy C; Jard S
Eur J Pharmacol; 1975; 32(02):214-20. PubMed ID: 1080112
[TBL] [Abstract][Full Text] [Related]
16. Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1, 2, 4, 7, and 8.
Grzonka Z; Kasprzykowski F; Kojro E; Darlak K; Melin P; Fahrenholz F; Crause P; Boer R
J Med Chem; 1986 Jan; 29(1):96-9. PubMed ID: 2416923
[TBL] [Abstract][Full Text] [Related]
17. Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues.
Vilhardt H; Bie P
Eur J Pharmacol; 1983 Sep; 93(3-4):201-4. PubMed ID: 6641789
[TBL] [Abstract][Full Text] [Related]
18. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
[TBL] [Abstract][Full Text] [Related]
19. Antidiuretic agonism and antagonism of some O-alkylated analogues of vasopressin containing 2-O-alkylated tyrosine.
Melin P; Lundin S; Vilhardt H; Lindeberg G; Larsson LE; Pliska V
Eur J Pharmacol; 1980 Oct; 67(2-3):173-7. PubMed ID: 7461030
[TBL] [Abstract][Full Text] [Related]
20. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
Lempicka E; Slaninova J; Olma A; Lammek B
J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
